UPC Analytics
ENDE
Overview · Filed: Jan 10, 2024

UPC_CFI_505/2023

METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)

InfringementMain Infringement ActionDusseldorf LDInfringementCase Closed
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • Sanofi Biotechnologies SAS

Respondents

Judges
  • Ronny Thomas
  • Berenice Thom
  • Andras Kupecz
  • Xavier Dorland-Galliot
Patents
  • EP3536712
CPC codes: A61K39/3955, C07K2317/76, A61P9/00, A61P43/00, A61P27/02, C07K2317/21, A61P7/00, C07K16/40, A61K2039/505, A61P11/00, A61P3/06, A61P9/10

Technology area: Biotech · Antibody

Sector: Organic Chemistry

Outcome
—
Filed: Jan 10, 2024
First decided: —
Language: English
Open on UPC Registry